Pennington retires after 34 years in medical oncology
Hoosier Cancer Research Network co-founder Kenneth L. Pennington, MD, recently retired from the IU Health Goshen Center for Cancer Care after 34 years of practice […]
Hoosier Cancer Research Network co-founder Kenneth L. Pennington, MD, recently retired from the IU Health Goshen Center for Cancer Care after 34 years of practice […]
Hoosier Cancer Research Network is excited to partner with individuals and organizations who are passionate about cancer research. Following are some of the groups who […]
Phase Ib/II Study of Neoadjuvant Pembrolizumab With Gemcitabine-Cisplatin (Cisplatin-Eligible) or Gemcitabine (Cisplatin-Ineligible) in Subjects With T2-4aN0M0 Urothelial Cancer: HCRN GU14-188 Status: Closed to Accrual
Hoosier Cancer Research Network, formerly known as Hoosier Oncology Group, recently honored Matthew Galsky, MD, as recipient of the Danny Danielson Translational Innovation Award. The […]
The Hoosier Oncology Group is proud to be among the major contributors acknowledged in House Concurrent Resolution No. 44 of the State of Indiana General […]
George Sledge, M.D., can add yet one more title to his long list of impressive credentials and titles: President of the American Society of Clinical […]
Following is a cumulative list of Hoosier Cancer Research Network publications in neuroeondocrine cancer.
Following is a cumulative list of Hoosier Cancer Research Network publications in gynecologic cancers.
Following is a cumulative list of Hoosier Cancer Research Network publications in bladder cancer.
Advances in research and patient care would not be possible without a strong network of advocates and advocacy organizations. As part of our mission, HCRN […]
Since Christopher A. Fausel, PharmD, MHA, BCOP, was appointed as Chairman of the Board of Directors for Hoosier Cancer Research Network in July 2013, he […]
A new Hoosier Cancer Research Network study is evaluating whether ginseng can help lessen fatigue in patients treated with regorafenib. The study, known as GI14-191, […]
Hoosier Cancer Research Network investigators will present their findings from the HCRN GU16-260 study during the 2022 American Society of Clinical Oncology Genitourinary Cancer Symposium […]
The American Society of Clinical Oncology’s ASCO20 Virtual Scientific Program will feature abstracts from three Hoosier Cancer Research Network studies. The program, taking place May […]
Four Hoosier Cancer Research Network (HCRN) investigator-initiated clinical trials were highlighted during the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL. […]
Two Hoosier Cancer Research Network studies, GU14-182 and MEL17-309, will be presented during the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 […]
This month, Hoosier Cancer Research Network highlights the Providence Cancer Institute in Portland, Ore., as a featured member of our network. Rachel E. Sanborn, MD, […]
The Hoosier Cancer Research Network study, LUN14-179, “A Phase II Trial of Concurrent Chemoradiation With Consolidation Pembrolizumab (MK-3475) for the Treatment of Inoperable or Unresectable […]
Erica Stringer-Reasor, MD, assistant professor of medicine in the Division of Hematology & Oncology at the University of Alabama at Birmingham (UAB), has been appointed […]
Hoosier Cancer Research Network investigators presented a trials in progress poster featuring the HCRN study GU17-295 during the American Society of Clinical Oncology’s 2020 Genitourinary […]
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter